Data completeness
0/8 — Limited
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MECLAN is a topical cream formulation of meclocycline sulfosalicylate, a tetracycline-class antibiotic indicated for bacterial skin infections. The drug works by inhibiting bacterial protein synthesis at the ribosomal level, making it effective against susceptible gram-positive and gram-negative organisms.
Pre-Launch
Early-stage commercialization phase with limited public spending data; team building and launch preparation activities expected.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Positions linked to MECLAN are currently limited but will expand significantly upon regulatory approval and commercial launch. This represents a ground-floor opportunity to build brand equity in the topical antibiotic segment under Johnson & Johnson's backing.
Brand ManagerField Sales Representative
Worked on MECLAN at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.